CONTEXT: Commercial announcement of another company acquiring RWE data assets | Patient search and identification meets data aggregation to produce de-identified, enriched, longitudinal data points derived from complex medical data sets
IMPACT: low
READ TIME: 1 min
Quality Level Mean [1 – 10]: 5
1. “Medexprim, the European expert in generating regulatory-grade datasets of aggregated images and clinical data, builds bridges between hospitals and biopharmaceutical companies to accelerate clinical research, and helps biopharmaceutical companies access specific datasets and design more successful, cost effective and faster clinical trials.”
2. “Clinerion and Medexprim will set up a joint offering which allows access to de-identified, enriched, longitudinal data points derived from complex medical data sets, which combine electronic health records and their corresponding clinical images, to improve research and help patients receive better care.”
3. “Ultimately, Clinerion is continuing to fulfil its mission of enabling a more granular patient data access for pre-screening, site selection and trial design, as well as providing much richer disease information to the clinical value chain.””
4. “Clinerion’s and Medexprim’s complementary expertise will enable more European university hospitals to leverage their Real-World data and will accelerate the implementation of a clinical data warehouse in the service of clinical research and the well-being of patients.”
5. “An accelerator of hospital clinical research and a tool for leveraging the data of its partner hospitals, Medexprim helps biopharmaceutical companies access specific datasets and design more successful, cost effective and faster clinical trials, through a network of European academic hospitals and global data partners.”